Susquehanna International Group
CSCI

Susquehanna International Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Susquehanna International Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,675
Closed -$47K – 13643
2022
Q4 		$47K Sell
3,675
-875
-19% -$13K ﹤0.01% 11430
2022
Q3 		$71K Buy
4,550
+3,894
+594% +$74.6K ﹤0.01% 11984
2022
Q2 		$13K Buy
656
+69
+12% +$1.73K ﹤0.01% 12464
2022
Q1 		$22K Buy
587
+429
+272% +$15.4K ﹤0.01% 12601
2021
Q4 		$6K Sell
158
-873
-85% -$46K ﹤0.01% 12977
2021
Q3 		$77K Sell
1,031
-3,712
-78% -$264K ﹤0.01% 12191
2021
Q2 		$416K Sell
4,743
-2,101
-31% -$200K ﹤0.01% 10032
2021
Q1 		$780K Buy
+6,844
New +$759K ﹤0.01% 8373
2020
Q2 		– Sell
-100
Closed -$5K – 11084
2020
Q1 		$5K Hold
100
– – ﹤0.01% 10109
2019
Q4 		$9K Sell
100
-167
-63% -$15.6K ﹤0.01% 9557
2019
Q3 		$28K Buy
267
+79
+42% +$17.1K ﹤0.01% 9905
2019
Q2 		$55K Buy
+188
New +$66.3K ﹤0.01% 9823
2019
Q1 		– Sell
-137
Closed -$40K – 9999
2018
Q4 		$40K Buy
+137
New +$32.7K ﹤0.01% 8550
2017
Q2 		– Sell
-159
Closed -$48K – 9945
2017
Q1 		$48K Buy
+159
New +$46.8K ﹤0.01% 8603

Other funds holding CSCI

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's CSCI Position: Q3 2025 in Review

Susquehanna International Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 11,504 shares — an estimated $39K sold.

Susquehanna International Group first reported a position in CSCI in Q1 2014 and held it in 24 quarters. The position peaked at $4.58M in Q1 2015. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

  • Susquehanna International Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 11,504 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $39K.
  • Susquehanna International Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2014 and held it in 24 quarters.
  • Susquehanna International Group's COSCIENS Biopharma Inc. Common Stock position peaked at $4.58M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.